Update on COVID-19 Vaccine Availability in States/UTs
The Union Government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country. The new phase of …
Covid -19 Vaccine registration now available through Whatsapp
(By- Jyoti Takkar) Coronavirus disease is an infectious disease and Coronavirus pandemic has changed complete lifestyle of people. It has influenced people’s …
Shri Ashwini Kumar Choubey receives second dose of COVID-19 vaccine
Union Minister of State for Health and Family Welfare Shri Ashwini Kumar Choubey along with his wife, Smt. Neeta Choubey were administered the second dose of …
Dr. Harsh Vardhan and Smt. Nutan Goel receives their second dose of COVID-19 Vaccine
Dr Harsh Vardhan,Union Minister of Health and Family Welfare along with his wife Smt. Nutan Goel were administeredthe second dose of the COVID-19 vaccine …
New age sustainable disinfectants and sanitizers may bring relief from chemical ones with side effects
The days of suffering from dry, itching hands due to rinsing them multiple times with chemical disinfectants and soap as protection against contact infection …
National Expert Group on Vaccine Administration for COVID-19 deliberates on strategy to ensure COVID-19 vaccines’ availability and its delivery mechanism
National Expert Group on Vaccine Administration for COVID-19, met for the first time on 12th August. The meeting was chaired by Dr V K Paul, Member Niti Aayog …
Department of Biotechnology provides seed funding for Gennova Biopharmaceuticals Ltd.’s novel mRNA based COVID 19 Vaccine candidate-HGCO19
The vaccine is likely to go to Clinical Trial before the year ends Vaccine Discovery Programme supported by the Department of Biotechnology, Govt. of India …
Covid-19 vaccine update
Dr KK Aggarwal A herd immunity of 60-70% is required to stop the spread of infection in the community; however, development of herd immunity will take time. …
Department of Biotechnology supported COVID 19 Vaccine -ZyCoV-D, designed and developed by Zydus,begins Adaptive Phase I/II clinical trials
BIRAC has announced that ZyCoV-D, the plasmid DNA vaccine designed and developed by Zydus and partially funded by the Department of Biotechnology, Government …